Reviewed by Laurence P. Banville, Esq.Frequently asked questions
What injuries are linked to Farxiga lawsuits?
Farxiga (dapagliflozin), an SGLT2 inhibitor diabetes drug, has been linked to diabetic ketoacidosis (DKA), Fournier’s gangrene (a severe genital/perineal infection), and urinary tract infections. The FDA has issued multiple warnings about these risks. Plaintiffs allege AstraZeneca failed to adequately warn patients and physicians about these dangers.
Can I file a Farxiga lawsuit in New York?
Yes. NY residents who suffered serious injuries from Farxiga may have grounds for a product liability or failure-to-warn claim against AstraZeneca. Under CPLR §214, you generally have three years from the date of injury, or under CPLR §214-c's discovery rule, three years from when you reasonably discovered the drug caused your harm.
What is the statute of limitations for a Farxiga lawsuit in NY?
New York's statute of limitations for personal injury claims is three years under CPLR §214. But under CPLR §214-c, New York's discovery rule for latent injuries from drug exposure, the clock may instead start from the date you discovered — or reasonably should have discovered — that Farxiga caused your condition. Waiting too long can permanently bar your claim, so consulting an attorney promptly is critical.
What should I do if I was harmed by Farxiga in New York?
Document everything: keep your prescription records, medical bills, hospital records, and a timeline of your symptoms. Stop or change medications only under a doctor’s supervision. Then contact a NY personal injury attorney experienced in pharmaceutical litigation to evaluate whether your case qualifies and to preserve evidence before the statute of limitations expires.